Page last updated: 2024-12-05

cyclohexane-1,3-diol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyclohexane-1,3-diol: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10433
SCHEMBL ID62366
MeSH IDM0050226

Synonyms (32)

Synonym
trans-1,3-cyclohexanol
cis-1,3-cyclohexandiol
504-01-8
1,3-cyclohexanediol
resorcitol
1,3-dihydroxycyclohexane
nsc30235
nsc-30235
cyclohexane-1,3-diol
AKOS005258329
A828101
C2323
trans-1,3-dihydroxycyclohexane
einecs 207-979-5
nsc 30235
ai3-06234
1,3-benzenediol, hexahydro-
FT-0606598
SCHEMBL62366
1,3-cyclohexanediol cis+trans
1,3-cyclohexanediol cis-trans
1,3-cyclohexanediol,c&t
mfcd00039458
cis-1,3-cyclohexanediol, >/=98%
F17088
BCP30890
1,3-benzenediol, hexahydro-; cyclohexane-1,3-diol; hexahydroresorcinol; 1,3-dihydroxycyclohexane;resorcitol
DTXSID60964654
AS-57120
CS-0135350
EN300-20001
SY007586
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.58 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index45.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]